$2.65
$-0.08 (-3.02%)
End-of-day quote: 05/10/2024
NasdaqCM:CASI
CASI Pharmaceuticals Annual Report
| Year | Year | 2023 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2010 | 2007 | 2006 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$33.88M | $15.14M | $4.13M | $0.00M | $0.00M | $0.00M | $0.05M | $0.02M | $3.69M | $7.40M | $6.89M | $5.92M | $0.51M | |
| GM % | Gross Margin % |
|
59.19% | 37.20% | 4.74% | 0.00% | 0.00% | 0.00% | 86.85% | 68.53% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| OM | Operating Margin |
|
-74.62% | -220.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -122.78% | 0.00% | 0.00% | -292.79% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-1.82 | $-2.76 | $-4.07 | $-3.16 | $-1.80 | $-1.70 | $-2.20 | $-9.20 | $-9.40 | $-30.80 | $-78.11 | $-39.60 | $-40.70 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
13.38m | 12.39m | 9.78m | 9.53m | 6.98m | 6.02m | 3.24m | 3.24m | 1.14m | 0.77m | 0.76m | 0.46m | 0.39m | |
| OCF | Operating Cash Flow |
|
$-19.97M | $-25.89M | $-23.24M | $-28.58M | $-6.40M | $-6.02M | $-5.51M | $-4.00M | $-4.96M | $-23.52M | $-20.77M | $-14.52M | $-16.42M | |
| FCF | Free Cash Flow |
|
$-41.74M | $-27.39M | $-23.67M | $-29.71M | $-7.33M | $-6.24M | $-5.54M | $-4.23M | $0.00M | $-23.63M | $-21.00M | $-14.77M | $-16.58M | |
| FCFS | Free Cash Flow Per Share |
|
$-1.66 | $-3.85 | $-3.88 | $-5.94 | $-1.19 | $-1.12 | $-1.71 | $-1.56 | $-5.13 | $-30.88 | $-32.14 | $-33.72 | $-49.08 |
